Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Omeros Corporation
*MAILING ADDRESS
201 Elliott Avenue West
*CITY
Seattle
*STATE
(Required for U.S. applicants)
Washington
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
98119
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Washington
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical preparations for the treatment of endothelial diseases and disorders, renal diseases, transplant complications,
ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders; biologics for the treatment of endothelial diseases and
disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
016
*IDENTIFICATION
Printed publications in the nature of brochures, pamphlets, newsletters, written articles and guidebooks in the field of medical information
and patient support
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
042
*IDENTIFICATION
Providing medical and scientific research information in the fields of pharmaceuticals and biopharmaceuticals
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
044
*IDENTIFICATION
Medical information services, namely, providing information concerning pharmaceutical and biopharmaceutical products, and therapeutic methods
in the fields of endothelial diseases and disorders, renal diseases, transplant complications, ischemia reperfusion injury, hematological, autoimmune, immunological and inflammatory related diseases
and disorders
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Anne H. Peck
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Cooley LLP
STREET
1299 Pennsylvania Avenue, Suite 700
CITY
Washington
STATE
District of Columbia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
20004
EMAIL ADDRESS
trademarks@cooley.com
OTHER APPOINTED ATTORNEY
Susan Piascik Christoff, Juliana Finley, Brian Focarino, Bobby A. Ghajar, Colette A. Ghazarian, Rebecca Givner-Forbes, Kelley B. Harrington,
Shannan Higgins, Ariana G. Hiscott, Brendan J. Hughes, Judd D. Lauter, John Paul Oleksiuk, Marcus D. Peterson, Elizabeth F. Reinhardt, Elisa Rosen, Dina Roumiantseva, Jane van Benten, and Colleen
Wellington-Caban
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97241241
Filing Date:01/27/2022
To the Commissioner for Trademarks:
MARK: IMPROVE THE OUTLOOK FROM THE INSIDE (Standard Characters, see mark)
The literal element of the mark consists of IMPROVE THE OUTLOOK FROM THE INSIDE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Omeros Corporation, a corporation of Washington, having an address of
201 Elliott Avenue West
Seattle, Washington 98119
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical preparations for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and
hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders; biologics for the treatment of endothelial diseases and disorders, renal diseases, transplant
complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 016: Printed publications in the nature of brochures, pamphlets, newsletters, written articles and guidebooks in the field of medical information and patient support
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 042: Providing medical and scientific research information in the fields of pharmaceuticals and biopharmaceuticals
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 044: Medical information services, namely, providing information concerning pharmaceutical and biopharmaceutical products, and therapeutic methods in the fields of
endothelial diseases and disorders, renal diseases, transplant complications, ischemia reperfusion injury, hematological, autoimmune, immunological and inflammatory related diseases and disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Anne H. Peck. Other appointed attorneys are Susan Piascik Christoff, Juliana Finley, Brian Focarino, Bobby A. Ghajar, Colette A. Ghazarian, Rebecca
Givner-Forbes, Kelley B. Harrington, Shannan Higgins, Ariana G. Hiscott, Brendan J. Hughes, Judd D. Lauter, John Paul Oleksiuk, Marcus D. Peterson, Elizabeth F. Reinhardt, Elisa Rosen, Dina
Roumiantseva, Jane van Benten, and Colleen Wellington-Caban. Anne H. Peck of Cooley LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is
located at
1299 Pennsylvania Avenue, Suite 700
Washington, District of Columbia 20004
United States
trademarks@cooley.com
Anne H. Peck submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1400 has been submitted with the application, representing payment for 4 class(es).
Declaration
Declaration Signature
Signature: /Tina J. Quinton/ Date: 01/26/2022
Signatory's Name: Tina J. Quinton
Signatory's Position: VP, Patents
Signatory's Phone Number: 650-843-5096
Signature method: Sent to third party for signature
Payment Sale Number: 97241241
Payment Accounting Date: 01/27/2022
Serial Number: 97241241
Internet Transmission Date: Thu Jan 27 11:10:29 ET 2022
TEAS Stamp: USPTO/BAS-XXX.XX.XXX.XXX-202201271110294
68644-97241241-810459e92eda98a9d857a8992
c5a5f339c46486c39e3d1936dc3c84a51fde1ab1
-DA-10294404-20220126190120428655